A recent study showing that serotonin 5-HT1A receptor upregulation is accompanied with anxiety/depression-like behavior in PD indicates that the 5-HT1A receptor could be an attractive therapeutic target for PD-associated depression (Lim et al. 2018b). Here, HTR1A is linked to depressive disorder.